Winners of 2023 ARVO research fellowships announced

Article

Three recipients will each receive up to $10,000 toward their research on a 1-year project that can go toward additional training in specialty equipment or research methodologies.

Winners of 2023 ARVO research fellowships announced

The Association for Research in Vision and Ophthalmology (ARVO) announced the winners of its 2023 ARVO Foundation Collaborative Research Fellowship recently.

According to an ARVO news release, Fellows José Arthur Milhomens Filho, MD; Maria Constanza Paz, PhD; Raba Thapa, PhD will each receive up to $10,000 toward their research on a 1-year project. These funds can go towards additional training in specialty equipment or research methodologies.

According to ARVO, the goal of the Fellowship is to pair early-career researchers from developing countries with collaborating scientists in well-established research laboratories to strengthen ophthalmic research capabilities worldwide.

José Arthur Milhomens Filho, MD, is a post-graduate student at the Escola Paulista de Medicina (EPM) - Universidade Federal de São Paulo (UNIFESP), Brazil. Filho plans to use this Fellowship on his research evaluating the levels of the inflammatory molecules in the tear and corneal epithelial cells of keratoconus patients, and if these can be used as biomarkers to identify greater severity and progression of the disease.

"As a native Brazilian, I am the first in my family to follow the area of Ophthalmology, so I am excited to keep pushing forward with my education," Filho said in the ARVO release. "I feel that this award means recognition of the importance of our project which aims to improve understanding of a particular disease with such a huge social impact as keratoconus."

Maria Constanza Paz, PhD, is an assistant researcher at the Centro de Investigación en Bioquímica Clínica (CIBICI)-Consejo Nacional de Investigación en Ciencia y Tecnología (CONICET), Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina. Paz will use the funding to research cellular and molecular mechanisms triggered by alpha2-Macroglobulin (a2M) in retinal neurodegeneration, an area in which little is currently known.

Thanks to the Fellowship, Paz said it "will enable development of novel therapeutic approaches, more specific and fit-for-the-purpose related with the ability to modulate autophagic flux and/or the deleterious effect of a2M."

Raba Thapa, PhD, is an associate professor of ophthalmology at the National Academy of Medical Sciences and a consultant vitreo-retinal surgeon at the Tilganga Institute of Ophthalmology, Nepal. Thapa will use the funding to explore the prevalence, pattern, and associated factors for retinal diseases among the population residing in high altitudes, since retinal diseases are the major cause of blindness in Nepal.

"The findings of the study will help to develop appropriate strategies in the future among the high-risk people to reduce the avoidable blindness from retinal diseases," said Thapa. “I am very grateful to the ARVO Foundation... This award will certainly help to boost my career in research works, networking and collaborations in the future for many needful research works in the field of ophthalmology and visual science for helping in reducing blindness especially to those living in remote areas and at low middle income countries. The research findings will also help for policy makers and other stakeholders working in reducing blindness globally."

For more information on the ARVO Foundation Collaborative Research Fellowship, visit ARVO’s website.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
Related Content
© 2025 MJH Life Sciences

All rights reserved.